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Background: Due to ongoing myocardial ischemia the left ventricle starts to decrease contractility in ischemic areas. As a result of negative 
remodeling hypokinesia is enlarging and affects non-ischemic regions by deterioration of its function. The present study examines the effects of local 
autologous EPC-Tx in non-ischemic areas versus non-ischemic areas in placebo-treated pigs.
Methods: 26 pigs obtained a special stent by percutaneous coronary intervention in the proximal left anterior descending coronary artery (LAD). 
During the following 21-28 days a high grade coronary stenosis developed inside the stent (>95) leading to an anterior-septal hypokinesia. At this 
point 100 ml of blood was withdrawn and EPC’s were separated using a Ficoll gradient and a special culture medium. Four days later, the hearts of 
the animals were examined by MRI, and afterwards randomized to EPC-Tx or Placebo injection (100 μl/injection). Injections were performed into the 
lateral, anterior and septal area in approximately 1cm steps from the apex to the base of the chronic ischemic zone which was determined priorly by 
MRI. Four weeks after injection a second exam was performed. For quantitative examination of local contractility the analysis was executed with the 
Medis® software system. The fibrotic myocardial tissue was stained by Sirius-red.
Results: After EPC-Tx there is no significant difference in the amount of fibrosis compared to placebo-treated animals within non-ischemic sectors 
(4,9±0,2%, vs. 5,8±0,2%, p>.05). However, the same areas show a significant increase of maximal wall thickening after EPC-Tx (179,8±2,4% vs. 
136,8±1,3%, p<.01). The increase of maximal contractility in the treatment group is similar to healthy age-matched control animals (179,8±2,4% 
vs. 162,4±1,9%, p<.01). Contractility expressed per amount of fibrosis in the examined area is significantly higher in EPC-Tx animals in contrast to 
placebo-treatment (65,8±7,78 vs. 40,67±5,26, p<.01)
Conclusions: Intramyocardial autologous EPC-Tx of the ischemic area improved contractility of the non-ischemic area. Thus, deterioration of the 
remodeling process in this region was abolished and contractility remained at normal levels.
